TD Cowen analyst Bill Katz lowered the firm’s price target on Carlyle to $41 from $45 and keeps a Hold rating on the shares. Heading into the Q2 reports, the firm curbed targets moderately for the alternative asset managers. For the traditional asset managers, TD generally raised its outlook, mostly due to above trend equities returns in Q2 and related model gearing.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CG:
- Baxter up 5% after WSJ report on Carlyle talks to buy kidney care unit
- Carlyle in talks to buy Baxter’s Vantive business for over $4B, WSJ reports
- Carlyle in advanced talks to buy Baxter’s Vantive business, WSJ reports
- Carlyle, KKR win $10B Discover Financial loan portfolio, FT reports
- Carlyle, KKR final bidders for Discover portfolio of student loans, FT says